XBiotech Inc
Cerrado
2.34 2.63
Resumen
Variación precio
24h
Mínimo
2.2800000000000002
Máximo
2.34
Ingresos | 21M -5.5M |
|---|---|
BPA | -0.181 |
Empleados | 87 |
EBITDA | 24M -5.1M |
Próximas Ganancias | 11 ago 2026 |
|---|
Capitalización Mercado | -4.9M 70M |
|---|---|
Apertura anterior | -0.29 |
Cierre anterior | 2.34 |
XBiotech Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
XBiotech Inc previsión
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de XBiotech Inc
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.